[go: up one dir, main page]

AU3410099A - Pharmaceutical compositions containing melatonin inclusion complexes - Google Patents

Pharmaceutical compositions containing melatonin inclusion complexes

Info

Publication number
AU3410099A
AU3410099A AU34100/99A AU3410099A AU3410099A AU 3410099 A AU3410099 A AU 3410099A AU 34100/99 A AU34100/99 A AU 34100/99A AU 3410099 A AU3410099 A AU 3410099A AU 3410099 A AU3410099 A AU 3410099A
Authority
AU
Australia
Prior art keywords
pharmaceutical compositions
compositions containing
inclusion complexes
containing melatonin
melatonin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU34100/99A
Inventor
Giampiero Besana
Roberto Golzi
Giancarlo Santus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Recordati SA
Original Assignee
Recordati SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati SA filed Critical Recordati SA
Publication of AU3410099A publication Critical patent/AU3410099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/4045Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU34100/99A 1998-03-13 1999-03-10 Pharmaceutical compositions containing melatonin inclusion complexes Abandoned AU3410099A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT98MI000510A IT1298731B1 (en) 1998-03-13 1998-03-13 PHARMACEUTICAL COMPOSITIONS CONTAINING COMPLEX INCLUSION WITH MELATONIN
ITMI98A0510 1998-03-13
PCT/EP1999/001539 WO1999047175A1 (en) 1998-03-13 1999-03-10 Pharmaceutical compositions containing melatonin inclusion complexes

Publications (1)

Publication Number Publication Date
AU3410099A true AU3410099A (en) 1999-10-11

Family

ID=11379301

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34100/99A Abandoned AU3410099A (en) 1998-03-13 1999-03-10 Pharmaceutical compositions containing melatonin inclusion complexes

Country Status (3)

Country Link
AU (1) AU3410099A (en)
IT (1) IT1298731B1 (en)
WO (1) WO1999047175A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3056220A1 (en) * 2007-04-11 2016-08-17 John A. Mccarty Hormone tablet and metods of preparation
US8691275B2 (en) 2011-01-28 2014-04-08 Zx Pharma, Llc Controlled-release melatonin compositions and related methods
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
ITMI20112042A1 (en) * 2011-11-10 2013-05-11 Eratech S R L POWDER TO RECONSTITUTE BEFORE INCLUDING MELATONIN AND INJECTABLE PREPARATION OBTAINABLE FROM SUCH POWDER.
WO2016142341A1 (en) * 2015-03-06 2016-09-15 Repoceuticals Aps Melatonin for preventing and treating radiation vaginitis and proctitis
NL2015272B1 (en) 2015-08-05 2017-05-02 Versailles B V Melatonin formulations and methods for preparation and use.
ITUB20156299A1 (en) * 2015-12-03 2017-06-03 S B M S R L Product comprising collagen and at least one micronized amorphous drug, a process for its preparation and related uses in the medical field.
WO2019038586A1 (en) 2017-08-19 2019-02-28 Ftf Pharma Private Limited Pharmaceutical composition of melatonin
EP3705117A1 (en) 2019-03-05 2020-09-09 Tradichem Industrial Services, S.L. Melatonin having improved water solubility, its preparation and uses thereof
EP4021411A4 (en) * 2019-08-30 2023-08-09 Vijayendrakumar Virendrakumarji Redasani Liquid pharmaceutical compositions of melatonin for oral and parenteral administration

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU730216B2 (en) * 1996-09-01 2001-03-01 Pharmos Corporation Solid coprecipitates for enhanced bioavailability of lipophilic substances
EP0867181A1 (en) * 1997-03-26 1998-09-30 Franciscus Wilhelmus Henricus Maria Merkus Nasal melatonin composition
CN1112184C (en) * 1998-04-13 2003-06-25 广州市美乐健生物技术有限公司 Melatonin slow-releasing agent and its production process

Also Published As

Publication number Publication date
IT1298731B1 (en) 2000-02-02
ITMI980510A1 (en) 1999-09-13
WO1999047175A1 (en) 1999-09-23

Similar Documents

Publication Publication Date Title
HUP0103256A3 (en) Thiobenzimidazole derivatives and pharmaceutical compositions containing the compounds
IL133293A0 (en) Pharmaceutical compositions comprising cyclodextrins
IL147970A0 (en) Pharmaceutical compositions containing tripeptides
AU3192700A (en) Medicinal compositions
AU6740298A (en) Pharmaceutical composition
AU4413299A (en) Stabilized pharmaceutical compositions
IL145290A0 (en) Pharmaceutical compositions comprising complexes
AU1574900A (en) Pharmaceutical compositions containing insulin
AU3556400A (en) Pharmaceutical compositions
AU2005300A (en) Medicinal compositions
AU1887401A (en) Medicinal composition
AU8107998A (en) Pharmaceutical compositions
HUP0000137A3 (en) Controller-release pharmaceutical composition containing anangetics
AU3976800A (en) Antiperspirant compositions
HUP0200747A2 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
AU6370299A (en) Pharmaceutical compositions containing tetrahydroisoquinoline compounds
AU7904998A (en) Pharmaceutical composition containing peptichemio
IL142534A0 (en) Pharmaceutical compositions containing an antigen-adjuvent
AU6464098A (en) Dental composition
AU3410099A (en) Pharmaceutical compositions containing melatonin inclusion complexes
AU6460400A (en) Pharmaceutical compositions
AU5326298A (en) Pharmaceutical compositions containing N-sulphonylindoline derivatives
AU9343098A (en) Pharmaceutical composition
AU1044799A (en) Pharmaceutical composition containing zafirlukast
AU6460200A (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase